Skip to content
HowShorted

Immunic, Inc. short interest in 2020

In 2020, Immunic, Inc.'s disclosed short interest ran from 0.53% of shares outstanding on 15 Jan 2020 to 4.50% on 31 Dec 2020, a change of +3.97 percentage points. The year's high was 7.10% on 30 Sep 2020 and its low 0.36% on 31 Jan 2020, averaging 2.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.88 days on 15 Dec 2020. Full history: Immunic, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Immunic, Inc. in 2020

2020 in figures

Start of year
0.53% (15 Jan 2020)
End of year
4.50% (31 Dec 2020)
Change
+3.97 pp
High
7.10% (30 Sep 2020)
Low
0.36% (31 Jan 2020)
Average
2.18%
Highest days to cover
4.88 (15 Dec 2020)
SEC filings marked
8

Every report in 2020

Immunic, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20200.53%3.89
31 Jan 20200.36%1.70
14 Feb 20200.37%2.55
28 Feb 20200.40%3.39
13 Mar 20200.39%4.59
31 Mar 20200.49%1.1010-K filed, results (8-K)
15 Apr 20200.48%2.18
30 Apr 20200.60%1.00
15 May 20201.14%1.0010-Q filed, results (8-K)
29 May 20200.51%1.00
15 Jun 20200.45%1.00
30 Jun 20201.04%1.00
15 Jul 20201.14%1.00
31 Jul 20200.94%1.00
14 Aug 20201.75%1.0010-Q filed, results (8-K)
31 Aug 20203.13%1.00
15 Sep 20205.13%1.24
30 Sep 20207.10%2.33
15 Oct 20204.69%2.41
30 Oct 20204.91%3.20
13 Nov 20203.79%3.43results (8-K), 10-Q filed
30 Nov 20205.06%2.96
15 Dec 20203.34%4.88
31 Dec 20204.50%3.64

See also: Immunic, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.